Literature DB >> 2034929

Protein inhibitors of crystallization.

F I Coe1, J H Parks, Y Nakagawa.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 2034929

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN： 0270-9295            Impact factor:   5.299


× No keyword cloud information.
  9 in total

1.  Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.

Authors:  Somchai Chutipongtanate; Yasushi Nakagawa; Suchai Sritippayawan; Jeeraporn Pittayamateekul; Paisal Parichatikanond; Bruce R Westley; Felicity E B May; Prida Malasit; Visith Thongboonkerd
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

2.  Inhibitors of in vitro mineralization from flexor tendons of rabbits and their role in biological mineralization.

Authors:  C D Tandon; M Forouzandeh; S Aggarwal; R K Jethi
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

3.  Kinetics of calcium oxalate crystal formation in urine.

Authors:  Norbert Laube; Florian Klein; Falk Bernsmann
Journal:  Urolithiasis       Date:  2016-06-21       Impact factor: 3.436

4.  Simultaneous measurements of calcium oxalate crystal nucleation and aggregation: impact of various modifiers.

Authors:  B Hess; U Meinhardt; L Zipperle; R Giovanoli; P Jaeger
Journal:  Urol Res       Date:  1995

Review 5.  A hypothesis of calcium stone formation: an interpretation of stone research during the past decades.

Authors:  Hans-Göran Tiselius
Journal:  Urol Res       Date:  2011-01-19

6.  Analysis of the soluble organic matrix of five morphologically different kidney stones. Evidence for a specific role of albumin in the constitution of the stone protein matrix.

Authors:  B Dussol; S Geider; A Lilova; F Léonetti; P Dupuy; M Daudon; Y Berland; J C Dagorn; J M Verdier
Journal:  Urol Res       Date:  1995

7.  The effects of citrate and urine on calcium oxalate crystal aggregation.

Authors:  H G Tiselius; A M Fornander; M A Nilsson
Journal:  Urol Res       Date:  1993

Review 8.  Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

9.  A novel calcium oxalate crystal growth inhibitory protein from the seeds of Dolichos biflorus (L.).

Authors:  Rakesh K Bijarnia; Tanzeer Kaur; Surinder K Singla; Chanderdeep Tandon
Journal:  Protein J       Date:  2009-05       Impact factor: 2.371
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.